tirzepatide fda ruling approves to treat sleep apnea May 18, 2026: FDA warns

This convenience is attracting a new group of patients who might have avoided the injectable versions

Off-label prescribing is a common practice physicians use to prescribe an FDA-approved drug at different doses or for reasons other than what the drug is approved to treat

Semaglutide, the drugs active ingredient, has a half-life of about seven days , so it may take up to 35 days for the drug to flush out of your system

Some anticipated side effects include nausea, but we remedy that with a b-12 injection

Some patients experience delayed or reduced absorption, while others absorb medications more quickly

Continuation is generally appropriate when symptoms are mild to moderate, there is a gradual improvement over time, and daily functioning is not significantly affected